2.3.1.B41	5637 cell	-	729849	
2.3.1.B41	A-375 cell	-	756871	
2.3.1.B41	adipose tissue	-	755904, 755918	
2.3.1.B41	artery	-	756672	
2.3.1.B41	astrocyte	-	756691	
2.3.1.B41	BEL-7402 cell	-	757530	
2.3.1.B41	brain	-	729145, 756392	
2.3.1.B41	BxPC-3 cell	-	756689	
2.3.1.B41	C2C12 cell	-	-, 755766, 758395	
2.3.1.B41	carcinoma cell	-	756689	
2.3.1.B41	cardiac fibroblast	-	739733	
2.3.1.B41	cardiac muscle fiber	-	756879, 756973, 758395	
2.3.1.B41	cardiomyocyte	-	738170	
2.3.1.B41	embryo	-	757931	
2.3.1.B41	embryoid body	-	756879	
2.3.1.B41	embryonic fibroblast	-	730101	
2.3.1.B41	embryonic stem cell	-	739132, 756407, 756879	
2.3.1.B41	endothelial cell	-	756672	
2.3.1.B41	endothelium	-	756672	
2.3.1.B41	G-361 cell	-	756871	
2.3.1.B41	gastrocnemius	-	-, 755766	
2.3.1.B41	HCCLM-3 cell	-	757530	
2.3.1.B41	heart	-	738170, 756672, 758395	
2.3.1.B41	HEK-293 cell	-	757236	
2.3.1.B41	HeLa cell	-	730527, 755787	
2.3.1.B41	HEP-3B cell	-	757530	
2.3.1.B41	Hep-G2 cell	-	737977, 756689, 757883	
2.3.1.B41	hepatocellular carcinoma cell	-	737977	
2.3.1.B41	hepatocyte	-	757644	
2.3.1.B41	hepatoma cell	-	757883	
2.3.1.B41	hippocampus	-	756392	
2.3.1.B41	HL-7702 cell	-	757530, 757644	
2.3.1.B41	HS-294T cell	-	756871	
2.3.1.B41	Huh-7 cell	-	737977, 757883	
2.3.1.B41	HUVEC cell	-	729362, 756672	
2.3.1.B41	kidney	-	-, 756672, 756689, 756973	
2.3.1.B41	liver	-	756672, 756689, 757530, 757644, 757883	
2.3.1.B41	lung	-	756672, 756689	
2.3.1.B41	MCF-7 cell	-	756689, 757667	
2.3.1.B41	MEF cell	-	758437	
2.3.1.B41	melanocyte	-	756871	
2.3.1.B41	mesenchymal stem cell	-	756407	
2.3.1.B41	MHCC-97H cell	-	757530	
2.3.1.B41	MHCC97-L cell	-	757530	
2.3.1.B41	muscle fibre	-	755766, 758395	
2.3.1.B41	myoblast	-	-, 755766	
2.3.1.B41	neural stem cell	-	757931	
2.3.1.B41	neuron	-	756392	
2.3.1.B41	ovarian cancer cell	-	738169	
2.3.1.B41	OVCAR-3 cell	-	738169	
2.3.1.B41	pancreas	-	756689	
2.3.1.B41	podocyte	-	756973	
2.3.1.B41	retinal microvascular endothelial cell	-	738283	
2.3.1.B41	SH-SY5Y cell	-	756392	
2.3.1.B41	SK-MEL-2 cell	-	756871	
2.3.1.B41	SK-MEL-28 cell	-	756871	
2.3.1.B41	skeletal muscle	-	-, 755766, 756973, 758395	
2.3.1.B41	skin	-	729520, 756871	
2.3.1.B41	SKOV-3 cell	-	738169	
2.3.1.B41	soleus	-	-, 755766	
2.3.1.B41	spinal cord	-	756691	
2.3.1.B41	spleen	-	756672, 756689	
2.3.1.B41	squamous cell carcinoma cell	-	729520	
2.3.1.B41	temporal lobe	-	756392	
2.3.1.B41	THP-1 cell	-	757667	
2.3.1.B41	UM-UC-3 cell	-	729849	
2.3.1.B41	umbilical vein endothelial cell	-	756672	
2.3.1.B41	vascular endothelial cell	-	756672	
2.3.1.B41	white adipose tissue	-	756689	
2.3.1.B41	WM-115 cell	-	756871	
2.3.1.B41	WM-35 cell	-	756871	
2.3.1.B41	WM-451Lu cell	-	756871	
2.3.1.B41	podocyte	a dramatic reduction in Sirt6 is detected in the podocytes in diabetic mice relative to those in control mice	-, 756973	
2.3.1.B41	keratinocyte	epidermal	729520	
2.3.1.B41	lung	fetal	757294	
2.3.1.B41	hepatoma cell	HCC cell, SIRT6 upregulation is quite prevalent in HCC tissues and closely correlated with worse overall survival, disease-relapse free survival, and HCC metastasis	757530	
2.3.1.B41	multiple myeloma cell	high expression	737930	
2.3.1.B41	brain	highly expressed in cortical and hippocampal regions and enriched in the synaptosomal membrane fraction	730473	
2.3.1.B41	hepatoma cell	increased SIRT6 expression in HCC, SIRT6 expression pattern and its association with HCC metastasis, overview	757644	
2.3.1.B41	myofibroblast	lung, level of SIRT6 in in vitro model of myofibroblast differentiation, overview	757294	
2.3.1.B41	embryonic fibroblast	MEF cells	755978	
2.3.1.B41	additional information	most of the melanoma cell lines exhibit significantly higher expression of SIRT6 protein and mRNA as assessed by immunoblot and RT-qPCR analyses, respectively	756871	
2.3.1.B41	bladder transitional cell carcinoma cell line	muscle invasive urothelial carcinoma of the bladder. Decline of SIRT6 expression when bladder cancer progresses from stage T2 to stage T4	729849	
2.3.1.B41	melanoma cell	overexpression of SIRT6 in human melanoma tissues	756871	
2.3.1.B41	additional information	SIRT6 and PP2A regulatory subunit (PPP2AR1A, the main Tau phosphatase) expression are positively correlated in normal brains, but this correlation is lost in Alzheimer's disease brains	756392	
2.3.1.B41	additional information	Sirt6 expression and Sirt6-wild-type-1 colocalization is suppressed in the glomeruli of patients with diabetic nephropathy (DN)	756973	
2.3.1.B41	additional information	Sirt6 expression is reduced in the kidney of streptozotocin(STZ)-induced diabetic mice	-, 756973	
2.3.1.B41	additional information	SIRT6 expression levels regulate NAD+ levels in different organs	756689	
2.3.1.B41	preadipocyte	SIRT6 expression pattern analysis during bovine preadipocyte differentiation, overview	755904	
2.3.1.B41	glioma cell	SIRT6 is down-regulated in human glioma tissues	729145	
2.3.1.B41	brain	SIRT6 is highly expressed in human brains but reduced in Alzheimer's disease patients, SIRT6 mRNA and protein levels are reduced in patients with Alzheimer's disease in temporal cortex and hippocampus	756392	
2.3.1.B41	retina	SIRT6 is highly expressed in the retina, controlling levels of histone H3K9 and H3K56 acetylation	730790	
2.3.1.B41	additional information	SIRT6 promoted HCC metastasis, expression analysis in HCC cell lines, overview. SIRT6 expression is significantly increased. SIRT6 is also upregulated in Hep3B and LO2 cells	757530	
2.3.1.B41	skin	sun-protected normal skin	729520